(Q53286507)

13 May 2018

title

Adjuvant chemolipiodolization reduces early recurrence derived from intrahepatic metastasis of hepatocellular carcinoma after hepatectomy. (English)

1 reference

13 May 2018

1 reference

hepatocellular carcinoma

1 reference

Masaki Ueno

1

1 reference

13 May 2018

Kazuhisa Uchiyama

2

1 reference

13 May 2018

Satoru Ozawa

3

1 reference

13 May 2018

Shinya Hayami

4

1 reference

13 May 2018

Yoshinobu Shigekawa

5

1 reference

13 May 2018

Masaji Tani

6

1 reference

13 May 2018

Hiroki Yamaue

7

1 reference

13 May 2018

publication date

26 May 2011

1 reference

13 May 2018

Annals of Surgical Oncology

published in

1 reference

13 May 2018

volume

18

1 reference

13 May 2018

issue

13

1 reference

13 May 2018

page(s)

3624-3631

1 reference

13 May 2018

https://scigraph.springernature.com/pub.10.1245/s10434-011-1800-6

exact match

0 references

cites work

Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1800-6

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1800-6

Clinical significance of hepatic resection in hepatocellular carcinoma: analysis by disease-free survival curves

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1800-6

Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1800-6

Adjuvant oral chemotherapy to prevent recurrence after curative resection for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1800-6

Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1800-6

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1800-6

Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1800-6

Prevention of intrahepatic recurrence by adjuvant (131)iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1800-6

A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1800-6

Interferon-beta is more potent than interferon-alpha in inhibition of human hepatocellular carcinoma cell growth when used alone and in combination with anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1800-6

Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1800-6

Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1800-6

Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1800-6

Clonal Origin of Recurrent Hepatocellular Carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1800-6

Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1800-6

10.1245/S10434-011-1800-6

21 January 2018

Identifiers

DOI

1 reference

13 May 2018

Dimensions Publication ID

1036928002

0 references

1 reference

13 May 2018